About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in New York | 26 Studies

Clinical Trials LupusNew York

Lupus Clinical Trials in New York

Find 26 clinical trials for lupus near New York, New York. Connect with research centers in your area.

All Lupus trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-26 of 26 trials

RecruitingA Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus NephritisThis Phase IIa, open-label, single-arm study includes an initial Safety Run-In followed by dose expansion to evaluate the safety, tolerability, cellular kinetics…NCT07328581·Chicago, Illinois and 3 others Enrolling by invitationElectromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how…NCT07221565·New York, New York UnknownNature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLEThis study to examines the impact of anifrolumab on disease activity, immune phenotypes, and development of neutralizing antibodies to quadrivalent influenza vaccine in patients…NCT04726553·New Haven, Connecticut and 4 others

Lupus Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).NCT03616964·Gilbert, Arizona and 158 others

TerminatedCOVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersThis is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additional doses of COVID-19 vaccine in participants with…NCT05000216·Los Angeles, California and 28 others

CompletedA Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the safety and tolerability of TAK-079 in comparison with matching placebo, administered once every 3 weeks over a 12-week dosing period…NCT03724916·Anniston, Alabama and 18 others

PreviousPage 2 of 2

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia